Use the column to the left to read important details and topics regarding each service in particular
We ecourage you to contact Ocean Blue Medical Research Center for more questions and/or information about our services.
Ocean Blue Medical Research Center lab services provides the experience, personalized research services and flexibility that keeps clients coming back. Tight timelines, difficult enrollment qualifications and unusual study guidelines are challenges our staff welcomes. They have enrolled thousands of participants for both inpatient and outpatient trials and works closely with you to customize data entry and other processes to meet your specific needs. Our center in Miami contains extensive security measures to ensure that study drug supplies, patient information, study samples and associated documentation remain confidential and secure.
Ocean Blue Medical Research Center has the ability to accommodate large, or even multiple, cohort trials, combined with our dedicated, experienced staff enables effective integrated planning and implementation for Phase I-IIb clinical trials.
Pharmacokinetics/Pharmacodynamics: Pharmacodynamics is often summarized as the study of what a drug does to the body, whereas pharmacokinetics is the study of what the body does to a drug, our Clinical Research team uses PK/PD studies both in vitro and in vivo as an essential part of a rational early compound screening strategy.
Bio-availability: Bioavailability must be considered when calculating dosages for non-intravenous routes of administration. As one of the essential tools in pharmacokinetics, our clinical research services scientists give it the attention it deserves.
Bio-equivalence: The clinical research services' experience with generic drug development programs, as well as our expertise in study design and regulatory knowledge, ensures smooth, efficient bioequivalence studies.
Dose ranging/multiple-dose tolerance: Finding the appropriate safe therapeutic dose and dose regimen is an important consideration in early-phase studies. Clinical research services' meticulous attention to detail ensures accurate results.
Drug-drug interactions: The clinical research services utilizes standard CYP450 probe substrates in studies to assess drug metabolism and evaluate drug interactions early in the drug development program.
ADME studies: Clinical research services uses radioisotopic labeling to precisely track the passage of a substance through a human system. By including radionuclides in its chemical composition, isotopes of different masses can be separated using mass accelerator spectrometry in microdose or microtrace ADME studies or the compound of interest can be detected using scintillation counting for typical ADME study designs.
First-in-Man (SAD/MAD): Ocean Blue Medical Research Center where a pharmaceutical test article, previously developed and assessed through in vitro or in vivo studies, is studied in human subjects for the first time presents a risk to volunteers.
Because we have the experience, the proper conditions, facilities and advanced capabilities at your disposition Ocean Blue Medical Research Center wants to be your primary provider for drug development solutions.